Page 28 - CIRN Annual Report 2017-18
P. 28

CIRN  |  2018 ANNUAL REPORT





             PROVINCIAL COLLABORATIVE NETWORK

             •   S Bolotin, C Johnson, S Quach, A Ambrose, S DeCoutere, SL Deeks SL, S Drews, A Faheem, K Green,
                 SA Halperin, L Hoang, F Jamieson, T Kollmann, A Marchand-Austin, D McCormack, A McGeer, M Murti,
                 AO Bba, A Rebbapragada, OG Vanderkooi, J Wang, B Warshawsky, N Crowcroft. Case-control study of
                 household contacts to examine immunological protection from Bordetella pertussis transmission - study
                 protocol. CMAJ Open. 2017 Dec 19;5(4):E872-E877.

             •   S Fathima, KA Simmonds, SJ Drews, LW Svenson, JC Kwong, SM Mahmud, S Quach, C Johnson,
                 KL Schwartz, NS Crowcroft, ML Russell. How well do ICD-9 physician claim diagnostic codes identify
                 confi rmed pertussis cases in Alberta, Canada? A Canadian Immunization Research Network (CIRN) Study.
                 BMC Health Serv Res. 2017 Jul 12;17(1):479.


             •   N Crowcroft. A multi-provincial approach to evaluating pertussis vaccine eff ectiveness in Canada using
                 administrative data. PHO Grand Rounds 2017

             •   N Crowcroft. A multi-provincial approach to evaluating pertussis vaccine eff ectiveness in Canada using
                 administrative data. TOPHC. March 2018

             •   J Kwong. Comparing the eff ectiveness of live attenuated and inactivated infl uenza vaccines in children and
                 adolescents during the 2012-13 to 2015-16 infl uenza seasons in Alberta, Canada: a Canadian Immunization
                 Research Network (CIRN) Study. Currently under review at JAMA Pediatrics.



             REFERENCE LABORATORY NETWORK
             •   S Bolotin. Population immunity to measles in Ontario, Canada at European Scientifi c Conference on
                 Applied Infectious Disease Epidemiology (ESCAIDE), 2017.


             •   S Bolotin. Population immunity to measles and varicella in Ontario. Public Health Ontario Grand Rounds,
                 Toronto 2017.

             •   S Bolotin. Population immunity to measles in Ontario, Canada, Vaccine Sciences Symposium, Toronto,
                 2017.

             •   S Bolotin. Calibration and Evaluation of Quantitative Antibody Titers for Varicella-Zoster Virus Using the
                 BioPlex 2000. ASM Clinical Virology Symposium, 2017.

             •   S Bolotin. Calibration and Evaluation of Quantitative Antibody Titers for Varicella-Zoster Virus Using the
                 BioPlex 2000. CIRN Annual General Meeting, 2017.

             •   TF Hatchette, H Scholz, S Bolotin, N Crowcroft, C Jackson, E McLachlan, A Severini. Calibration and
                 Evaluation of Quantitative Antibody Titers for Measles Virus by Using the BioPlex 2200. Clin Vaccine
                 Immunol. 2017 Jan 5; 24(1).


             •   S Pillet. Cell-Mediated Immunity Elicited by the RVSV-EBOV Ebola Vaccine in a phase 1 dose-acceleration
                 clinical trial. CIRN Annual General Meeting, 2017.


             •   J Shapiro. Phrenice nerve paralysis following immunization with Gardasil. CIRN Annual General Meeting,
                 2017.
   23   24   25   26   27   28   29   30   31   32   33